중환자실에서 적용한 반코마이신(Vancomycin) 내성 장구균의 감염관리 전략 효과 = Effects of Infection Control Strategies for Vancomycin Resistant Enterococci in Intensive Care Units

다국어 초록 (Multilingual Abstract)

Purpose: This study was to examine whether VRE infection control strategies have an effect on the decrease in
incidence rates for VRE acquisition and VRE nosocomial infection in ICU. Methods: All the patients were examined
for VRE carriers on ICU admission. Among them, patients hospitalized for over 48 hours were investigated for VRE
acquisition rates and VRE nosocomial infection rate using VRE infection control strategies in ICU for the experimental
group from September 2007 to April 2008. Before that, incidence of VRE acquisition and VRE nosocomial
infection for the control group without Intervention were investigated from May to August 2007 retrospectively.
Results: VRE acquisition rate in clinical specimens was 0.6% in the experimental group, that was significantly lower
when compared to the control group. VRE carrier rate at admission to ICU was 15.4%. Out of 182 VRE carriers,
180 patients were identified by the active surveillance culture. Conclusion: These results suggested that active
surveillance culture at admission was considered to be an essential measure for detection of VRE carrier. But
without strict isolation and adherence rating after each intervention, hand washing and contact isolation alone did
not significantly decrease VRE nosocomial infection, although it did significantly decrease incidence of VRE acquired
from clinical specimen.

참고문헌 (Reference)

1 Pelz, R, K., "Vancomycin-sensitive and vancomycin resistant enterococcal infections in the ICU: Attributable costs and outcomes" 28 (28): 692-697, 2002

2 Metallidis, S., "Vancomycin resistant enterococci, colonizing the intestinal tract of patients in a university hospital in Greece" 10 (10): 179-184, 2006

3 Yeh, K. M., "Vancomycin resistant enterococci(VRE) carriage and infection in intensive care units" 10 (10): 177-183, 2004

4 Ostrowky, B. E., "Vancomycin resistant enterococci in intensive care units" 159 (159): 1467-1472, 1999

5 McNeil, S. A., "Vancomycin resistant enterococcal colonization and infection in liver transplant candidates and recipients: A prospective surveillance study" 42 (42): 195-203, 2006

6 Warren, D. K., "The epidemiology of vancomycin resistant enterococci colonization in a medical intensive care unit" 24 (24): 238-241, 2003

7 Siddigui, A. H., "The effect of active surveillance for vancomycin resistant enterococci in high-risk units on VRE incidence hospital-wide" 30 (30): 40-43, 2002

8 Kim, K. M., "The Nationwide surveillance results of nosocomial infections along with antimicrobial resistance in intensive care units of sixteen university hospitals in Korea, 2004" 11 (11): 79-86, 2006

9 Park, J. W., "Susceptibility test of vancomycin resistant enterococci" 24 (24): 133-137, 1992

10 Shadel, B. N., "Surveillance for vancomycin resistant enterococci: Type, rates, costs, and implications" 27 (27): 1068-1075, 2006

11 Muto, C. A., "SHEA guideline for preventing nosocomial transmission of multidrug-resistant strains of staphylococcus aureus and enterococcus" 24 (24): 362-386, 2003

12 Maclntyre, C. R., "Risk factors for colonization with vancomycin resistant enterococci in a Melbourne hospital" 22 (22): 624-631, 2001

13 Hayden, M. K, "Reduction in acquisition of vancomycin resistant enterococci after enforcement of routine environmental cleaning measures" 42 (42): 1552-1560, 2006

14 Kim, D. R., "Rectal surveillance culture of vancomycin resistant enterococci(VRE) colonization among patient hospitalized in the intensive care unit" 19 (19): 87-97, 2001

15 Furtado, G. H., "Prevalence and factors associated with rectal vancomycin resistant enterococci colonization in two intensive care units in Sao Paulo, Brazil" 9 (9): 64-69, 2005

16 Laclercq, R., "Plasmidmediated resistance to vancomycin and teicoplanin in Enterococcus faecium" 319 (319): 157-161, 1988

17 Peta, M., "Outbreak of vancomycin resistant enterococcus spp. in an Italian general intensive care unit" 12 (12): 163-169, 2006

18 Lee, S. O., "Korean nosocomial infections surveillance system (KONIS) report: Data summary from July through September 2006" 11 (11): 113-128, 2006

19 Montecalvo, M. A., "Infection control measures reduce transmission of vancomycin resistant enterococci in an endemic setting" 131 (131): 269-272, 1999

20 Mayhall, C. G, "Hospital Epidemiology and Infection Control(3rd ed.)" Lippincott Williams & Wilkins 1659-1700, 2004

21 Stosor, V., "Enterococcus faecium bacteremia; does vancomycin resistance make a difference?" 158 (158): 522-527, 1998

22 Yoon, S. W., "Efficacy of infection control strategies to reduce transmission of vancomycin resistant enterococci in a tertiary care hospital in Korea: A 4-years follow-up study" 28 (28): 493-495, 2007

23 Song, X., "Effect of nosocomial vancomycin resistant enterococcal bacteremia on mortality, length of stay, and costs" 24 (24): 251-256, 2003

24 Choi, S. J., "Detection of rectal VRE carriers and control in the ICU of an university Hospital" 4 (4): 284-, 1999

25 Cheong, H. J., "Colonization rate, risk factor for acquisition and genetic diversity of vancomycin resistant enterococci isolated from rectal culture of patients in intensive care units from ten large hospitals in Korea" 34 (34): 276-284, 2002

26 Kim, J. M, "1996 National nosocomial infection surveillance in Korea" 2 (2): 157-176, 1997